SSTR2 and neuroendocrine neoplasm: Finally, both tumor regions exhibited strong membranous reactivity for the G-protein-coupled receptor, somatostatin receptor 2 (SSTR2) in > 50% tumor cells (Fig. 2I), analogous to score 3 described in neuroendocrine tumors [13].